Cargando…
Diabetes, hypertension, and cardiovascular disease development
BACKGROUND: We aimed to compare cardiovascular risks among participants with T2DM with and without subsequent HTN and participants with HTN with and without subsequent T2DM. METHODS: From January 1, 2000, to December 31, 2018, we identified 16,236 matched pairs of T2DM participants with and without...
Autores principales: | Yen, Fu-Shun, Wei, James Cheng-Chung, Chiu, Lu-Ting, Hsu, Chih-Cheng, Hwu, Chii-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722333/ https://www.ncbi.nlm.nih.gov/pubmed/34980154 http://dx.doi.org/10.1186/s12967-021-03217-2 |
Ejemplares similares
-
Cardiovascular outcomes of metformin use in patients with type 2 diabetes and chronic obstructive pulmonary disease
por: Yen, Fu-Shun, et al.
Publicado: (2022) -
The Risk of Nephropathy, Retinopathy, and Leg Amputation in Patients With Diabetes and Hypertension: A Nationwide, Population-Based Retrospective Cohort Study
por: Yen, Fu-Shun, et al.
Publicado: (2021) -
Parental Income Level and Risk of Developing Type 2 Diabetes in Youth
por: Yen, Fu-Shun, et al.
Publicado: (2023) -
Sulfonylureas may be useful for glycemic management in patients with diabetes and liver cirrhosis
por: Yen, Fu-Shun, et al.
Publicado: (2020) -
Is insulin the preferred treatment in persons with type 2 diabetes and liver cirrhosis?
por: Yen, Fu-Shun, et al.
Publicado: (2021)